FIELD: medicine; radiation diagnostics.
SUBSTANCE: invention can be used for non-invasive assessment of pressure in the portal vein system. Magnetic resonance imaging of the spleen is performed. In the T2-weighted image, the spleen is marked in the axial section. Using the “pixel value” program, the volumetric mass of the spleen (VMS, cm3) is calculated. With VMS values from 161 to 299 cm3, the pressure in the portal vein system is defined as equal to from 250 to 400 mm H2O, which corresponds to stage I portal hypertension. With VMS values from 300 to 339 cm3, the pressure in the portal vein system is defined as equal to from 401 to 600 mm H2O, which corresponds to stage II portal hypertension. For VMS values greater than or equal to 400 cm3, the pressure in the portal vein system is defined as greater than or equal to 601 mm H2O, which corresponds to stage III portal hypertension. With VMS values from 141 to 160 cm3, the pressure in the portal vein system is defined as equal to from 11 to 249 mm H2O, which corresponds to the risk of developing portal hypertension. With VMS values from 80 to 140 cm3, the pressure in the portal vein system is defined as equal to 5 to 10 mm H2O, which corresponds to the norm.
EFFECT: method provides non-invasive assessment and monitoring of pressure in the portal vein system by determining VMS.
1 cl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR NON-INVASIVE DIAGNOSTICS OF MORPHOFUNCTIONAL DISORDERS IN SPLEEN WITH PORTAL HYPERTENSION | 2022 |
|
RU2815256C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF THE PRESENCE OR ABSENCE OF SPLENOMEGALY AND HYPERSPLENISM SYNDROMES IN PATIENTS WITH HEPATITIS AND LIVER CIRRHOSE | 2022 |
|
RU2790367C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING PORTAL HYPERTENSION IN DIFFUSE LIVER DISEASES | 2020 |
|
RU2741369C1 |
METHOD FOR PREDICTING HEPATIC CHRONIC DIFFUSE DISEASES | 2004 |
|
RU2250751C1 |
METHOD FOR PREDICTING AETIOLOGY OF SIALOADENITIS IN PATIENTS WITH CHRONIC HEPATITIS AND LIVER CIRRHOSIS | 2023 |
|
RU2806122C1 |
METHOD FOR VERIFICATION OF SYMPTOMATIC AND MINIMAL HEPATIC ENCEPHALOPATHY IN CHRONIC HEPATITIS AND LIVER CIRRHOSIS | 2022 |
|
RU2792568C1 |
METHOD AND DEVICE FOR HEPATIC HEMODYNAMICS ESTIMATION | 2007 |
|
RU2372022C2 |
METHOD OF TREATING VARIX DILATATION OF ESOPHAGUS IN CASE OF PORTAL HYPERTENSION | 2010 |
|
RU2435591C1 |
METHOD FOR ASSESSING PROBABILITY OF DEVELOPING NEPHRITIS IN DIFFUSE LIVER DISEASES | 2022 |
|
RU2792321C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF SUBCLINICAL AND STAGES OF CLINICAL ACUTE KIDNEY INJURIES | 2023 |
|
RU2797880C1 |
Authors
Dates
2024-01-09—Published
2023-02-27—Filed